공지사항 - 아이리움의 새로운 소식을 확인해 보세요.

NOTICE & NEWS

EYEREUM OPHTHALMIC CLINIC

ESCRS 37TH CONGRESS OF THE ESCRS PARIS

OCULUS - PENTACAM Holladay Report

Dr. Jin-Young Choi Presented 10-Year Clinical Outcomes of V4c Implantable Collamer Lens (ICL) at the 4th EVO ICL APAC Experts Summit

2026.05.22 1658

At the 4th EVO ICL APAC Experts Summit held in Guangzhou, China, Dr. Jin-Young Choi from EYEREUM EYE CLINIC (Seoul, Korea) presented long-term clinical data on the safety of EVO ICL.

STAAR SURGICAL 4th EVO ICL APAC EXPERTS SUMMIT

NameRegion
SUDARSHAN KHOKHARINDIA
JIN YOUNG CHOIKOREA
YE SHENCHINA
FRANCIS MAHUSA
JULIAN TSINGAPORE

STAAR SURGICAL

EVO ICL

In this lecture, Dr. Choi presented:

“A Decade of Evidence: 10-Year Clinical Outcomes Demonstrating the Long-Term Safety of EVO ICL”

Jin Young Choi, M.D.

EYEREUM EYE CLINIC, Seoul, Republic of Korea.

Program Date 2026.4.25

Event
THE 4th EVO ICL APAC EXPERTS SUMMIT
Organization
STAAR SURGICAL
Product
EVO ICL

The presentation was based on clinical research conducted by the medical team at EYEREUM EYE CLINIC, published in the January 2025 issue of the American Journal of Ophthalmology:

“10-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics”

AMERICAN JOURNAL OF OPHTHALMOLOGY

ORIGINAL ARTICLES
Volume 269, P1-10, January 2025

Ten-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics

Byunghoon Chung 1,# · Jin Young Choi 1,# · David S.Y. Kang 1 · Kangyoon Kim 1 · Bo Yi Kim 2 · Tae-im Kim 2,3,4

  • Affiliations & Notes
  • Article Info

Abstract

Purpose

This study aimed to evaluate the long-term clinical outcomes of V4c Implantable Collamer Lens (ICL) implantation for myopia correction over a 10-year period.

Dr. Choi shared long-term clinical findings demonstrating stable outcomes in key parameters including endothelial cell density (ECD), vault dynamics, and visual acuity, with no major complications observed throughout the 10-year follow-up period.

Highlights

• Long-term stability of endothelial cell density (ECD) and vault changes

• Sustained visual outcomes over a 10-year follow-up period

• Absence of major complications during long-term observation

• Clinical evidence supporting the long-term safety profile of EVO ICL

The 4th EVO ICL APAC EXPERTS SUMMIT

A Decade of Evidence: 10-Year Clinical Outcomes Demonstrating the Long-Term Safety of EVO ICL

Jin Young Choi, M.D. EYEREUM EYE CLINIC, Seoul, Republic of Korea. Program Date 2024.4

STAAR SURGICAL THE 4th EVO ICL APAC EXPERTS SUMMIT EYEREUM EYE CLINIC, Seoul, KR

EVO ICL Evolution in Visual Freedom

30 YEARS Collamer FIRST & ONLY ONE

Event Participant Roles

  • Moderator
  • Speaker

During the meeting, Dr. Choi also received the “Global Contribution to EVO ICL Scientific Publication” Award, recognizing his contributions to EVO ICL clinical research and scientific publications.

CERTIFICATION

In recognition for leading Global Contribution to EVO ICL Scientific Publications

JIN YOUNG CHOI

THE 4TH EVO ICL APAC EXPERTS SUMMIT

EYEREUM EYE CLINIC will continue striving to provide patients with trusted medical care and excellence in vision correction.